Objective-To estimate the odds of morbidity and mortality associated with cesarean compared to vaginal delivery for breech fetuses delivered from 23 to 24 6/7 weeks gestational age (GA).
Introduction
With technological gains in neonatal intensive care capabilities, the threshold to provide antenatal interventions to improve survival has decreased to earlier gestational ages. Even in the face of rising periviable cesarean rates, 1, 2 the optimal mode of delivery for breech periviable neonates remains controversial, and it remains unclear whether cesarean delivery in the periviable period actually improves neonatal outcomes. 2 In light of the known increase in maternal morbidity and implications for future pregnancies associated with classical cesarean, 3 it is critically important that we have ample evidence to guide mode of delivery decisions at periviable gestational ages (GA). If cesarean does not confer substantial benefits to neonates, it is difficult to justify the added morbidity to mothers.
Many studies consider neonatal mortality and morbidity but often do not report outcomes by mode of delivery, 4, 5 and those studies that do examine mode of delivery often describe only mortality without morbidity-related outcomes. 2, [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] Furthermore, no randomized control trials of adequate size have compared planned vaginal delivery with planned cesarean for periviable neonates. Therefore, the literature leaves obstetricians ill-equipped to provide evidence-based recommendations and counseling to patients for periviable mode of delivery decisions.
The purpose of this study is to fill this gap in current knowledge by describing neonatal morbidity and mortality by mode of delivery for breech periviable fetuses. To do so, we aim to estimate the odds of neonatal morbidity and mortality associated with cesarean compared to vaginal delivery of breech fetuses delivered between 23 and 24 6/7 weeks GA.
Materials and Methods

Study Design and Population
We conducted a retrospective cohort study, analyzing state-level maternal and infant hospital discharge data, linked to birth and death certificate data, for California, Missouri, and Pennsylvania from 2000-2009. The Institutional Review Board (IRB) of the departments of health in California, Missouri, and Pennsylvania, and the Children's Hospital of Philadelphia approved this study. The data were input by the departments of health for each respective state; then cleaned and validated using sources including birth certificates and maternal and infant hospital data, with strong concordance (e.g. mode of delivery is over 99.5% concordant). The records were created by linking birth certificate data with maternal hospital discharge records and newborn hospital discharge data records, or death certificate data in the event of a fetal demise. Records were linked using previously described methods. 16 With these techniques, more than 98% of birth and death certificates are matched to maternal and newborn hospital records. 17 These data have been utilized extensively in our and others' publications. [18] [19] [20] [21] Live singleton births and 'in-hospital' fetal deaths occurring between 23 and 24 6/7 weeks of reported gestational age were included in the analysis. Because periviable births that are not resuscitated at the time of the delivery may potentially be classified as a fetal death, 22 it was important that fetal deaths not be excluded entirely from the analysis. We sought to distinguish these types of fetal deaths from fetal deaths that occurred out of the hospital or as intrauterine demises. Such deaths were designated as 'outpatient' or 'intrauterine' fetal deaths using criteria described by Phibbs et al. in previous work 22 and excluded from the analysis. (See Appendix A) Fetal anomalies were also excluded.
Variable Selection and Data Analysis
The primary predictor of interest was cesarean section (ICD 669.7x and 74.x), which had to be documented in the maternal or the infant record. Ultimately, documentation from the maternal record is reflected in all but 28 of the 8157 cases (99.0%). Breech neonates were identified by the following ICD-9 codes: 652.2, 652.20, 652.21, 652.23, and 763.0. Mortality-related outcomes of interest included: 'Overall survival' (defined as 6-month corrected age among intubated and non-intubated neonates) and survival to >24 hours, >1 week, and >6-month corrected age among neonates for whom intubation was performed or attempted (designated by ICD-9 codes 96.01, 96.02, 96.03, 96.04, 96.05 and CPT code 31500). Morbidity outcomes included: respiratory distress syndrome (RDS), bronchopulmonary dysplasia (BPD), grade III/IV intraventricular hemorrhage (IVH), necrotizing enterocolitis (NEC), retinopathy of prematurity (ROP), and asphyxia. Also included were composite outcome measures of 'Major Morbidity' designated as BPD, grade III/IV IVH, NEC, or asphyxia and a 'Composite' for death or asphyxia. ICD-9 codes used for specific diagnoses are listed in Appendix B. Maternal sociodemographic characteristics were also considered, including age in three categories (<18, 18-35, >35); race or ethnicity, designated in four categories (White, Black, Hispanic and Other); parity in four categories (0, 1, 2, 3 or more), education in two categories (<high school education or ≥high school education), median ZIP code income (<$20,000, $20,000-$40,000, $40,000-60,000, > $60,000) to approximate household income, and insurance payer (Fee For Service (FFS), Health Maintenance Organization (HMO), Federally Insured, Uninsured, and Other). In an effort to control for potential confounding factors, sociodemographic characteristics (insurance, race, and age) associated with mode of delivery were included as covariates in the final models. Likewise, maternal comorbidities, pregnancy complications, and delivery indications were also included in the full model, specifically: preexisting diabetes (DM), gestational diabetes (GDM), chronic hypertension (cHTN), pregnancy induced hypertension (PIH), preterm labor, preterm premature rupture of membranes (PPROM), placental abruption, repeat cesarean, placenta previa, and chorioamnionitis. ICD-9 codes used for specific diagnoses are listed in Appendix B. Finally, year of delivery was included because the incidence of cesarean increased over time in our cohort.
We conducted all analyses using SAS 9.2. Descriptive statistics were calculated using chisquared tests and Fisher's exact test as appropriate. Logistic regression was performed for multivariable analyses, which included potential modifying factors such as sociodemographic factors, maternal comorbidities, pregnancy complications, and delivery indications in the model. Delivery hospital was also included as a fixed effect to account for potential clustering of outcomes at the level of the delivery hospital. We initially examined the relationship between mode of delivery and mortality and morbidity in the overall cohort. Separate analyses were conducted which excluded 'emergent indications,' designated as fetal distress, PIH, previa, and abruption. We reasoned that these indications typically require immediate delivery and may also be associated with poorer outcomes regardless of mode of delivery. We also examined survival over 3 time periods among the subset of neonates that were intubated. Finally, we constructed separate models to evaluate the potential interaction between cesarean delivery and birthweight in relationship to morbidity and mortality. Statistical tests were considered significant at α=.05, adjusted for multiple comparisons using the Bonferroni correction.
Results
Study Population
Our study population was comprised of 8157 maternal/infant observations. Among these, we identified 1854 (22.9%) breech deliveries that comprised our final study cohort. Table 1 provides overall baseline sociodemographic and clinical characteristics for the mother and infant pairs, stratified by GA and mode of delivery. 77.9% of mothers were age 18-35. 21.6% of the women were Black, 32.8% Hispanic, and 34.4% White. Approximately 27.6% of women had less than a high school education, and 50.0% were federally insured. Overall, 45.5% and 76.6% of women delivering 23-and 24-week breech neonates were delivered by cesarean.
Women who were delivered by cesarean differed significantly from women who were not delivered by cesarean across parity, insurer, and educational categories (p<.01 for each). Mode of delivery also differed based on maternal comorbidities. Compared to women who delivered vaginally, women delivered by cesarean were more likely to have PIH (7.89% vs. 1.66%, p=<.01) and a prior cesarean delivery (16.04% vs. 8.90%; p<.01); and less likely to have birth weight of <=500g (10.41% vs. 22.51%; p <.01). Table 2 presents the absolute incidence and adjusted odds of 'overall survival' (includes all intubated and non-intubated neonates) for 23-and 24-week breech neonates in our study population, stratified by mode of delivery. Among the entire cohort of neonates delivered by cesarean at 23 weeks, the incidence of overall survival for cesarean-born neonates was 52.2% (175/335) compared to 22.9% (94/402) for vaginally-born neonates. Survival among this group was statistically significantly higher (AOR 3.98, 95% CI=2.24, 7.06) for those delivered by cesarean as compared to those who had a vaginal delivery in multivariable analyses. At 24 weeks, the overall survival among neonates delivered by cesarean was 65.0% (556/856), compared to a survival of 41.0% (107/261) for vaginally delivered neonates. In multivariable analysis, at 24 weeks, breech neonates delivered by cesarean, when compared to vaginal delivery, experienced greater survival in the overall cohort (AOR 2.91, 95% CI=1.76, 4.81). These associations remained statistically significant even after excluding emergent indications. Table 3 presents neonatal morbidity among intubated and non-intubated survivors, comparing cesarean and vaginal delivery by delivery indication and GA. Among intubated and non-intubated 23-week cesarean-born neonates who survived beyond 6-month corrected age, no differences were found in morbidity outcomes by mode of delivery. However, among those delivered for non-emergent indications, cesarean-born neonates were significantly more likely to experience each of the following: sepsis (AOR 3.62, 95% CI=1.78, 7.40), NEC (AOR 7.90, 95% CI=1.03, 60.57), and RDS (AOR 6.84, 95% CI=3.20, 14.63). Moreover, 'Major Morbidity', defined as BPD, IVH, NEC or asphyxia, was nearly 3 times as high for neonates delivered via cesarean for non-emergent indications compared to those delivered vaginally (AOR 2.83, 95% CI=1.37, 5.84).
Absolute Incidence and Adjusted Odds of Overall Survival by Mode of Delivery
Morbidity among Survivors by Mode of Delivery and Gestational Age (GA)
Similar findings were noted among 24-week breech presenting neonates. Among intubated and non-intubated neonates delivered for all indications, no significant differences in morbidity were identified. However, 24-week cesarean-born neonates delivered for nonemergent indications were more likely to experience BPD (AOR 2.09, 95% CI=1.05, 4.16), sepsis (AOR 2.06, 95% CI=1.11, 3.84), RDS (AOR 4.11, 95% CI=2.03, 8.32), and ROP (AOR 4.49, 95% CI=1.86, 10.82). Likewise, 'Major Morbidity' was twice as high among 24-week breech neonates delivered by non-emergent cesarean (AOR 2.07, 95% CI=1.11, 3.86) compared to those delivered vaginally. Table 4 presents the adjusted odds of surviving for >24 hours, >1 week, and >6 months corrected age by mode of delivery and indication for 23-and 24-week neonates who were intubated. Among intubated neonates, we found that cesarean-born 23-week neonates were significantly more likely to survive for 1 week (AOR 2.22, 95% CI=1.01, 4.87), but there was no difference in the likelihood of surviving 24 hours (AOR 1.44, 95% CI=0.46, 4.47) or to 6-month corrected age (AOR 1.77, 95% CI=0.83, 3.74) based on mode of delivery. Furthermore, when we limited the analysis to non-emergent indications for cesarean, there was no difference in survival at any time interval based on mode of delivery.
Survival over Time among Intubated Neonates by Mode of Delivery
Findings differed for 24-week neonates. At 24 weeks, intubated breech neonates delivered by cesarean, when compared to vaginal delivery, experienced greater survival at the 24 hour and 1 week intervals; however, no difference was observed in likelihood of survival to 6-month corrected age (AOR=1.81, 95% CI=0.72, 4.54). These associations remained even after excluding emergent indications.
Additional Analyses
In the analysis that adjusted for the effect of clustering at the level of the delivery hospital, our results remained largely unchanged. Table 5 reveals the results of an analysis performed to evaluate the potential interaction between cesarean delivery and birth weight in relationship to morbidity and mortality. This analysis showed no difference in mortality for cesarean-born neonates weighing <500g (AOR=0.46 95% CI=0.12, 1.79). Separate analyses were also performed to evaluate the cesarean rate over time. The prevalence of cesarean delivery increased over time. However, the association between mode of delivery and neonatal morbidity and mortality did not change over the time frame of this study.
Comment
We set out to estimate the odds of morbidity and mortality associated with cesarean compared to vaginal delivery for breech periviable fetuses. Our findings demonstrate a survival advantage with cesarean delivery among the entire cohort of intubated and nonintubated 23-and 24-week breech neonates. However, the odds of major neonatal morbidity among survivors were increased with cesarean performed for non-emergent indications. Furthermore, among the subset of intubated neonates, while the odds of short-term survival increased for 23-and 24-week neonates delivered by cesarean, their survival was no different beyond 6-month corrected age. Moreover, those intubated 23-week neonates delivered by cesarean for non-emergent indications were no more likely to survive at any time interval than those delivered by vaginal delivery. Finally, cesarean did not confer a survival benefit to neonates weighing <500g.
Other studies have reported a survival benefit for periviable neonates delivered by cesarean. Reddy et al. recently studied neonatal outcomes by attempted mode of delivery in a cohort of 24-32 week neonates. 15 Among 388 breech presenting 24-28 week deliveries, attempted vaginal delivery was associated with a higher rate of mortality (25.2% vs. 13.2%). Unfortunately, it was difficult to interpret the relevance of these findings for periviable neonates because 24-week deliveries were grouped with deliveries up to 28 weeks, and 23-week deliveries were not included. Malloy et al. studied vital statistics from more than 120000 22-31 week neonates and reported a survival advantage among 22-25 week neonates delivered by cesarean (61.5% compared to 37.8%). This survival advantage was primarily attributable to a greater survival in the first 24 hours of life. 6 In our initial analysis of the entire cohort of intubated and non-intubated breech neonates, we too found a survival advantage for cesarean-born neonates. However, for intubated neonates, this survival advantage was short-lived. For example, while cesarean-born 23-week breech neonates were more likely to survive from 24 hours to 1 week, they were no more likely to survive to 6-month corrected age. Moreover, this short-term survival advantage likely reflects confounding by indication for delivery, because when we excluded non-emergent indications for cesarean, there was no longer a statistically significant association between mode of delivery and survival at any time interval for 23-week breech neonates.
neonates compared to vaginally-born neonates, but only when cesarean was performed for non-emergent indications. We were concerned that our results may be biased if obstetricians were more likely to deliver 'sick' or distressed babies by cesarean, resulting in greater morbidity among cesarean survivors. However, after excluding distressed and emergent deliveries, we noted greater, rather than attenuated, morbidity among the cesarean cohort. This may suggest that physician and fetal factors matter less in emergent decision-making; whereas, in non-emergent circumstances, physician judgments about survivability and/or parental preferences for intubation have a greater influence on clinical decision-making and outcomes. We sought to attend to this possible source of bias by calculating survival in a cohort of intubated neonates, and, indeed, we found that this attenuated the initially observed relationship between cesarean and survival.
There are limitations to the conclusions we can draw from these findings. Due to the limitations of the data set, we are unable to determine if the patterns of cesarean observed reflect institutional practice, maternal preference, or physician guidance. When we controlled for hospital as a fixed effect, there were no major differences in the overall findings. This suggests that institutional practice may not be a driving factor. Another limitation of the study is that we identified our predictor and outcome variables by ICD-9 codes, not primary chart abstraction. This limits our ability to distinguish planned cesarean from unplanned cesarean and creates the risk for misclassification. However, this method allows for a large, population-based cohort that is needed to study these relatively rare events. The large cohort also allowed for stratified analysis to specifically focus on the association of cesarean and outcomes for breech presenting 23-and 24-week pregnancies. Finally, other unmeasured confounders, such as the administration of antenatal corticosteroids, may play a significant role in decision-making and actually account for the associations that we observed.
In closing, our study provides a more nuanced understanding of factors that may explain previous reports that cesarean confers a survival advantage for periviable neonates. In particular, our findings suggest that, for intubated 23-and 24-week breech neonates delivered by cesarean, this survival advantage is shortlived. Furthermore, we find no survival advantage for 23-week neonates when cesarean is performed for non-emergent indications. Additionally, we find that this short-term survival advantage can come at the expense of significant morbidity. In particular, we observed increased morbidity among intubated and non-intubated neonates delivered by cesarean for non-emergent indications. These findings have important clinical implications, particularly for the care of 23-week breech presenting fetuses. What parents consider to be a meaningful absolute difference in survival may not be consistent with what physicians designate as 'clinically significant' difference; and this may vary from parent to parent. Likewise, with survival time -some parents may find added days to weeks of survival to be meaningful; while others find it painstaking. These 'quality vs. quantity' of life determinations are best made with and by parents. Furthermore, as providers, we contend with numerous uncertainties-both in regards to where any given child will fall in the potential spectrum of disability, and what impact a classical cesarean will have on future reproductive outcomes for the mother. With such uncertainties, and poor prognostic capabilities available, these clinical deliberations clearly call for shared decision-making to occur between patients and providers. Together, patients and providers must consider and explicitly discuss the inherent trade-offs related to neonatal mortality and morbidity, maternal morbidity, and implications for future pregnancies. 
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Appendix B
The following ICD9 CM codes were used to designate maternal and fetal characteristics included as covariates in the models: 
